Delivery included to the United States

GnRH Analogues in Prostatic Cancer: The Way Forward

GnRH Analogues in Prostatic Cancer: The Way Forward 4th International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva, February 1996: Proceedings. Supplement Issue: European Urology 1996, Vol. 30, Suppl. 1

1st edition

Paperback (23 Oct 1996)

Not available for sale

Out of stock

This service is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Publisher's Synopsis

The treatment of patients with metastatic carcinoma of the prostate poses a great challenge to urologists. Androgen ablation is still the basic therapy for advanced disease and can be achieved either surgically or chemically. In this setting GnRH agonists such as leuprorelin play an increasingly important role. One of the problems of androgen ablation is hormonal resistance, often occurring after 18-23 months, which necessitates second-line treatment of tumors. This publication discusses both current therapeutic issues and the urgent need for new, effective strategies to counteract this situation. Quality-of-life issues and the importance of epidemiological information are also given due consideration. This valuable exchange of information by experts in the field will be of interest to all clinicians and researchers concerned with advanced prostatic carcinoma.

Book information

ISBN: 9783805563680
Publisher: S. Karger
Imprint: Karger
Pub date:
Edition: 1st edition
Language: English
Weight: 210g
Height: 230mm